Not all sufferers with CLL call for therapy. Irrespective of all the latest developments, the iwCLL even now recommends watchful observation for individuals with asymptomatic disorder.86 This suggestion relies on a minimum of two randomized trials evaluating observation to either chlorambucil monotherapy or fludarabine, cyclophosphamide and rituxim